|
AKAP8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
6.6812999577337E-11 |
| Normal-vs-Stage3 |
2.99760216648792E-15 |
| Normal-vs-Stage4 |
1.75126579904372E-12 |
| Stage1-vs-Stage2 |
9.814000E-01 |
| Stage1-vs-Stage3 |
1.799000E-01 |
| Stage1-vs-Stage4 |
3.744000E-02 |
| Stage2-vs-Stage3 |
4.035400E-01 |
| Stage2-vs-Stage4 |
1.319010E-01 |
| Stage3-vs-Stage4 |
3.897800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.3473000004538E-07 |
| Normal-vs-Asian |
6.20249962501873E-10 |
| Caucasian-vs-AfricanAmerican |
6.585200E-01 |
| Caucasian-vs-Asian |
2.549800E-01 |
| AfricanAmerican-vs-Asian |
7.213400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.48450174164827E-14 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
4.536800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.72639680329212E-12 |
| Normal-vs-Age(81-100Yrs) |
4.22060000000446E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.457800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.848000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.156400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.621600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.808800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.676400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.1658000005107E-07 |
| Classical-VS-Follicular |
2.071600E-01 |
| Classical-VS-Other |
5.319400E-01 |
| Classical-VS-Normal |
1.62470037423645E-12 |
| Tall-VS-Follicular |
7.001500E-04 |
| Tall-VS-Other |
1.014820E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
8.530400E-01 |
| Follicular-VS-Normal |
1.78101977610368E-12 |
| Other-VS-Normal |
2.780300E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
3.4806046933511E-11 |
| N0-vs-N1 |
4.331400E-01 |
|
|
